FDA Approves STIMATE — Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. confirmed the FDA approval of the generic version of STIMATE (desmopressin acetate), a nasal hormone replacement therapy originally approved in 1994. The market implication is that Ferring now has approval to introduce a less expensive alternative to the branded product, a move likely to drive uptake in treating central diabetes insipidus and nocturnal enuresis.